Avience Biomedicals IPO
The Avience Biomedicals IPO was a ₹30.24 crore SME issue (fresh issue only), open for bidding from 18 Jun to 22 June 2026 at a price band of ₹196 to ₹208. The final issue price was ₹208. Investors bid for 37,06,80,000 shares through 1,92,952 applications. Shares listed on NSE SME on 25 June 2026 at ₹395.20, 90.0% above the issue price, and closed the first day at ₹414.95.
- Listing gain at open
- +90.0%₹395.20 vs ₹208
- Issue price
- ₹208Band ₹196 to ₹208
- Lot size
- 600 sharesMinimum ₹2,49,600
- Issue size
- ₹30.24 crore
- Subscribed
- Not available
- Listed
- 25 Jun 2026NSE SME
Price and lots
Avience Biomedicals IPO details
NSE issue details| Bidding dates | 18 Jun 2026 to 22 Jun 2026 |
| Listing date | 25 June 2026 |
| Price band | ₹196 to ₹208 |
| Final issue price | ₹208 |
| Face value | ₹10 per share |
| Lot size | 600 shares, minimum 2 lots for individuals |
| Minimum investment | ₹2,49,600 (1,200 shares, our calculation) |
| Issue size | ₹30.24 crore (our calculation from the NSE issue details) |
| Type of issue | 100 % Book Building, Fresh issue only |
| Listed on | NSE SME |
| NSE symbol | AVIENCE |
| ISIN | INE0V9I01017 |
| Lead managers | Fintellectual Corporate Advisors Private Limited |
| Registrar | Skyline Financial Services Private Limited |
Subscription and listing
Avience Biomedicals IPO subscription and listing
NSE and BSEFinal subscription
NSE issue details| Category | Shares bid | Applications |
|---|---|---|
| QIBs | 5,38,37,400 | 172 |
| Non-institutional | 12,37,09,800 | 31,836 |
| Individual investors | 19,31,32,800 | 1,60,944 |
| Total | 37,06,80,000 | 1,92,952 |
For this SME issue NSE publishes shares bid and applications by category, not times subscribed.
Listing day
Our calculation: gains vs issue price| NSE | |
|---|---|
| Open | ₹395.20 |
| High | ₹414.95 |
| Low | ₹395.20 |
| Close | ₹414.95 |
| Gain at open | +90.0% |
| Gain at close | +99.5% |
| Shares traded | 7,26,000 |
Latest: closed at ₹250.00 on NSE on 6 November 2026, +20.2% vs the issue price (our calculation). Past returns say nothing about future returns.
How it compares
How the Avience Biomedicals IPO compares
Our calculation: 2026 SME IPOs on IPO24by7Among 78 SME IPOs of 2026 on our tracker, its listing gain of 90.0% at open ranks 3rd of 75. By issue size it ranks 64th. The median listing-day gain at open for SME IPOs this year is +1.0%. See all 2026 IPOs with listing gains or the IPO calendar for June 2026.
Other SME IPOs listed in June 2026
| IPO | Listed | Issue price | Subscribed | Gain at open |
|---|---|---|---|---|
| Clay Craft India | 24 Jun 2026 | ₹203 | - | +3.9% |
| Utkal Speciality Industries India | 17 Jun 2026 | ₹66 | - | 0.0% |
| GenXAI Analytics | 12 Jun 2026 | ₹116 | - | −20.0% |
Allotment
Avience Biomedicals IPO allotment status
- Open the registrar's pageSkyline Financial Services Private Limited is the registrar. Open its allotment page.
- Select Avience Biomedicals LimitedOlder issues may move to an archive list on the registrar's site.
- Enter your PAN, application number or DP IDUse the details you applied with.
- Or check your demat accountAllotted shares were credited before the listing day.
Documents
Questions
Avience Biomedicals IPO FAQs
What was the Avience Biomedicals IPO price band?
The price band was ₹196 to ₹208 per share and the final issue price was ₹208. The face value is ₹10 per share.
What was the Avience Biomedicals IPO lot size?
One lot was 600 shares. Individual investors had to apply for at least 2 lots, so the minimum was ₹2,49,600.
What was the Avience Biomedicals IPO listing price?
It opened at ₹395.20 on NSE SME on 25 June 2026, a gain of 90.0% over the issue price of ₹208 (our calculation). It closed the day at ₹414.95.
How do I check Avience Biomedicals IPO allotment status?
Skyline Financial Services Private Limited is the registrar. Select Avience Biomedicals Limited on its allotment page and enter your PAN, application number or DP ID. You can also check on the NSE or BSE application status page.
Was the Avience Biomedicals IPO a fresh issue or an offer for sale?
Fresh issue only, as stated in the NSE issue details.
Who were the lead managers of the Avience Biomedicals IPO?
Fintellectual Corporate Advisors Private Limited.
Sources: NSE public issue information and IPO detail pages; NSE and BSE end-of-day bhavcopy files. Gains, issue size and minimum investment are our calculations. This page is information only, not a recommendation.